Breast Cancer; Prevention.There is no known way to prevent breast cancer. But there are some things you can do to reduce your risk of breast cancer. Approved in 1998, the drug tamoxifen has been shown to slash the risk of breast cancer in high-risk women by up to 50 percent. Also, preliminary results of a 2006 study on postmenopausal women found that the osteoporosis drug raloxifene was as effective as tamoxifen at lowering breast cancer risk, with slightly fewer side effects. The study, called STAR (Study of Tamoxifen and Raloxifene The Study of Tamoxifen and Raloxifene or STAR is a clinical trial designed determine how the drug raloxifene compares with the drug tamoxifen in reducing the incidence of breast cancer in postmenopausal women who are at increased risk of the disease. )--one of the largest breast cancer prevention studies ever--compared both drugs, with raloxifene pulling just slightly ahead of tamoxifen. If you have a high risk for breast cancer, talk to your health care professional about tamoxifen, raloxifene or other similar drugs to prevent breast cancer. Although prevention is difficult, you have a much better prognosis if you can find and treat breast cancer early. To do that, follow this advice: At age 40 for women at an average risk of breast cancer, begin having screening mammograms every year. For women at high risk of breast cancer, starting at age 30 or an age determined by your health care professional, begin having annual screening mammograms together with magnetic resonance imaging magnetic resonance imaging (MRI), noninvasive diagnostic technique that uses nuclear magnetic resonance to produce cross-sectional images of organs and other internal body structures. (MRI 1. (application) MRI - Magnetic Resonance Imaging. 2. MRI - Measurement Requirements and Interface. ). To make sure you get the best possible mammogram, look for the FDA certificate, which should be prominently displayed at the facility. Facilities not meeting FDA requirements may not lawfully perform mammography. If you're in your 20s and 30s and at an average risk, have your health care professional examine your breasts at least once every three years and annually thereafter. Become familiar with how your breasts feel and what is "normal" for you; examine your breasts periodically and see a health care professional if you feel or see any changes that don't go away after one menstrual cycle. Eat a healthy diet rich in fruits and vegetables, maintain your ideal body weight, exercise regularly, and drink in moderation, if at all. A University of Washington (Seattle) study found that exercise and lack of obesity in adolescence significantly delayed the onset of breast cancer, including onset in high-risk women who carried genetic mutations for the disease. Engage in frequent and regular physical exercise. Some studies suggest it may reduce your breast cancer risk. If you're at very high risk for breast cancer because of a strong family history of breast and ovarian cancer, an inherited breast cancer gene breast cancer gene(s) See BRCA1, BRCA2. abnormality or previous breast cancer, talk to your health care professional about a prophylactic mastectomy. Prophylactic mastectomy is an aggressive preventive surgery that removes both breasts before any cancer is detected. It can reduce the risk of breast cancer by approximately 90 percent, but doesn't eliminate the risk entirely. Removing the ovaries (prophylactic oophorectomy) may also be a preventive choice for women with an inherited breast cancer gene abnormality, since the risk for ovarian cancer is also greater for these women. Visit www.breastcancer.org for more information. References Genomic Health, Inc. 2008. "What is Oncotype DX?" Available at http://www.genomichealth.com Accessed April 2008. "What is breast cancer?" The American Cancer Society. September 2007. http://www.cancer.org. Accessed March 2008. "How many women get breast cancer?" The American Cancer Society. September 26, 2007. http://www.cancer.org. Accessed March 2008. "How is breast cancer staged?" The American Cancer Society. September 2007. http://www.cancer.org. Accessed March 2008. "Abortion, miscarriage, and breast cancer risk." The National Cancer Institute. http://www.cancer.gov. Accessed March 2008. Ries LAG, Harkins D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2003. Bethesda, MD: National Cancer Institute; 2006. Vogel VG. Management of the high-risk patient. Surg Clin North Am. 2003;83(4):733-751. "ACS (Asynchronous Communications Server) See network access server. Advises MRIs for Some at High Risk of Breast Cancer." The American Cancer Society. March 28, 2007. Accessed March 28, 2007. "FDA approves Tykerb for advanced breast cancer patients." The U.S. Food and Drug Administration. 2007. http://www.fda.gov San Antonio Breast Cancer Symposium, Dec. 14-17, 2006. Donald Berry, PhD, department of biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston. Peter Ravdin, MD, PhD, department of biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston. Eric Winer, MD, Dana-Farber Cancer Institute, Boston. "Detailed Guide: Breast Cancer--What are the Key Statistics for Breast Cancer?" American Cancer Society copyright 2007. http://www.cancer.org. Accessed February 2007. "Breast self-exams: One way to detect breast cancer." Mayo Clinic. July 1, 2005. http://www.mayoclinic.com. Accessed September 15, 2005. "Mammograms." Womenshealth.gov. National Women's Health Information Center. US Department of Health and Human Services Noun 1. Department of Health and Human Services - the United States federal department that administers all federal programs dealing with health and welfare; created in 1979 Health and Human Services, HHS . Office on Women's Health. March 2002. http://www.4women.gov. Accessed September 15, 2005. "Sentinel Node Biopsy Sentinel node biopsy A newer procedure performed in order to determine whether breast cancer has spread to auxiliary (underarm) lymph nodes. A blue radioactive tracer and/or blue dye is injected into the area of the breast tumor. ." National Cancer Institute. http://www.nci.nih.gov. U. Veronesi, et al. "Sentinel Node Biopsy May Be as Good as Regular Lymph Node Biopsy Lymph Node Biopsy Definition A lymph node biopsy is a procedure in which all or part of a lymph node is removed and examined to determine if there is cancer within the node. ," New England Journal of Medicine The New England Journal of Medicine (New Engl J Med or NEJM) is an English-language peer-reviewed medical journal published by the Massachusetts Medical Society. It is one of the most popular and widely-read peer-reviewed general medical journals in the world. , August 7, 2003; last updated Sept. 2003.http://www.breastcancer.org. Accessed March 2004 "Prophylactic Mastectomy." Last updated February 2004. http://www.breastcancer.org. Accessed March 2004 "Bone Marrow Or Stem Cell Transplant Helps Reduce Breast Cancer Relapses," 1999. American Society of Clinical Oncology Conference, Atlanta, Georgia. "Breast Cancer." CancerNet. National Cancer Institute. National Institutes of Health. http://www.cancer.gov. Accessed November 2003. Canadian Medical Association Journal The Canadian Medical Association Journal (CMAJ) is a general medical journal that is published biweekly by the Canadian Medical Association (CMA). It is considered to be one of the top six general medical journals; the others being the 2001;164:1837-1846,1851-1852. "20-Year Follow-up of a Trial Comparing Total Mastectomy with Lumpectomy Lumpectomy Definition A lumpectomy is a type of surgery used to treat breast cancer. It is considered "breast-conserving" surgery because in a lumpectomy, only the malignant tumor and a surrounding margin of normal breast tissue are " New England Journal of Medicine, This Week in the Journal. October 2002. http://content.nejm.org. Accessed November 2002. "The Facts for Life." The Komen Foundation. http://www.komen.org. Accessed November 2003. "Updated Breast Cancer Screening This article or section recently underwent a major revision or rewrite and needs further review. You can help! X-ray mammography Mammography is still the modality of choice for screening of early breast cancer, since it is relatively fast, reasonably accurate, and Guidelines Released" American Cancer Society, May 15, 2003. http://www.cancer.org. Accessed November 2003. Breast Cancer: Detailed Guide. American Cancer Society. 2003. http://www.cancer.org. Accessed May 2003. "Cancer Facts and Figures 2003" American Cancer Society. http://www.cancer.org. Accessed May 2003. King MC, et al. "Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA BRCA One of two genes (designated BRCA1 and BRCA2) that help repair damage to DNA, but when inherited in a defective state increase the risk of breast and ovarian cancer. 1 and BRCA2." Science. 2003;302(5645):643-646. http://www.sciencemag.org. Accessed November 2003. Gross PE, et al. "A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer" New England Journal of Medicine. 2003;340:1793-1802. http://content.nejm.org. Accessed November 2003. "Summary from the General and Plastic Surgery Devices Panel Meeting--October 14 and 15, 2003." US Food and Drug Aministration. Center for Devices and Radiological Health The Center for Devices and Radiological Health (CDRH) is the branch of the United States Food and Drug Administration responsible for the premarket approval of all medical devices, as well as overseeing the manufacturing, performance and safety of these devices. . October 2003. http://www.fda.gov. Accessed November 2003. Coombes R, Hall E, Gibson L, et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med. 2004;350:1081-1092. Howell A, Cuzick J, Baum M, et al. ATAC Trialists' Group. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet. 2005;365(9453):60-2. "General information about breast cancer." The National Cancer Institute. June 22, 2005. http://www.cancer.gov. Accessed January 2006. Piccart-Gebhart MJ, Procter M, Leyland-Jones B et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med. 2005;353(16):1659-72. Romond E. H., Perez E. A., Bryant J, et al. Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer. N Engl J Med 2005; 353:1673-1684, Oct 20, 2005 "Study of Tamoxifen and Raloxifine (STAR) Trial." The National Cancer Institute. Updated 4/26/06. http://www.cancer.gov. Accessed April 26, 2006. "What are the risk factors for breast cancer?" American Cancer Society. September 2006. http://www.cancer.org. Accessed February 2007. "What is breast cancer?" American Cancer Society. September 2006. http://www.cancer.org. Accessed February 2007. Keywords: breast cancer, risk of breast cancer, family history, tamoxifen |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion